Fonte: Cellular Oncology. Unidades: IQ, BIOINFORMÁTICA
Assuntos: NEOPLASIAS PANCREÁTICAS, BIOMARCADORES
ABNT
GOMES FILHO, Sandro Mascena et al. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer. Cellular Oncology, v. 43, p. 445–460, 2020Tradução . . Disponível em: https://doi.org/10.1007/s13402-020-00498-5. Acesso em: 21 ago. 2024.APA
Gomes Filho, S. M., Santos, E. O. dos, Bertoldi, E. R. M., Scalabrini, L. C., Heidrich, V., Dazzani, B., et al. (2020). Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer. Cellular Oncology, 43, 445–460. doi:10.1007/s13402-020-00498-5NLM
Gomes Filho SM, Santos EO dos, Bertoldi ERM, Scalabrini LC, Heidrich V, Dazzani B, Levantini E, Reis EM, Bassères DS. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer [Internet]. Cellular Oncology. 2020 ; 43 445–460.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1007/s13402-020-00498-5Vancouver
Gomes Filho SM, Santos EO dos, Bertoldi ERM, Scalabrini LC, Heidrich V, Dazzani B, Levantini E, Reis EM, Bassères DS. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer [Internet]. Cellular Oncology. 2020 ; 43 445–460.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1007/s13402-020-00498-5